Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?
Operable pancreatic cancer is characterized by a high risk of recurrence. Efforts are made to incorporate new therapies. Throughout the world there is a lack of uniform recommendations concerning the adjuvant treatment of pancreatic cancer patients, due to confusing evidence-based data. The patient...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-06-01
|
Series: | Contemporary Oncology |
Subjects: | |
Online Access: | https://www.termedia.pl/Chemoradiotherapy-for-locally-advanced-pancreatic-cancer-patients-is-it-still-an-open-question-,3,27625,1,1.html |
id |
doaj-7a2a8654f0994cc3813e7469fbf8d6a1 |
---|---|
record_format |
Article |
spelling |
doaj-7a2a8654f0994cc3813e7469fbf8d6a12020-11-25T00:57:29ZengTermedia Publishing HouseContemporary Oncology1428-25261897-43092016-06-0120210210810.5114/wo.2016.6006627625Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?Emilia SawickaAnna MirończukMarek Z. WojtukiewiczEwa SierkoOperable pancreatic cancer is characterized by a high risk of recurrence. Efforts are made to incorporate new therapies. Throughout the world there is a lack of uniform recommendations concerning the adjuvant treatment of pancreatic cancer patients, due to confusing evidence-based data. The patients recruited to clinical trials differ from the population of patients treated in everyday practice. These differences have an influence on tolerance of treatment, toxicity and results of therapy. The decision on administration of adjuvant treatment is made individually and differs from center to center. A review of the literature concerning both results and tolerance of postoperative chemoradiotherapy of pancreatic cancer patients is presented.https://www.termedia.pl/Chemoradiotherapy-for-locally-advanced-pancreatic-cancer-patients-is-it-still-an-open-question-,3,27625,1,1.htmlpancreatic cancer adjuvant chemoradiotherapy radiotherapy gemcitabine 5-fluorouracil toxicity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Emilia Sawicka Anna Mirończuk Marek Z. Wojtukiewicz Ewa Sierko |
spellingShingle |
Emilia Sawicka Anna Mirończuk Marek Z. Wojtukiewicz Ewa Sierko Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question? Contemporary Oncology pancreatic cancer adjuvant chemoradiotherapy radiotherapy gemcitabine 5-fluorouracil toxicity |
author_facet |
Emilia Sawicka Anna Mirończuk Marek Z. Wojtukiewicz Ewa Sierko |
author_sort |
Emilia Sawicka |
title |
Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question? |
title_short |
Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question? |
title_full |
Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question? |
title_fullStr |
Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question? |
title_full_unstemmed |
Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question? |
title_sort |
chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question? |
publisher |
Termedia Publishing House |
series |
Contemporary Oncology |
issn |
1428-2526 1897-4309 |
publishDate |
2016-06-01 |
description |
Operable pancreatic cancer is characterized by a high risk of recurrence. Efforts are made to incorporate new therapies. Throughout the world there is a lack of uniform recommendations concerning the adjuvant treatment of pancreatic cancer patients, due to confusing evidence-based data. The patients recruited to clinical trials differ from the population of patients treated in everyday practice. These differences have an influence on tolerance of treatment, toxicity and results of therapy. The decision on administration of adjuvant treatment is made individually and differs from center to center. A review of the literature concerning both results and tolerance of postoperative chemoradiotherapy of pancreatic cancer patients is presented. |
topic |
pancreatic cancer adjuvant chemoradiotherapy radiotherapy gemcitabine 5-fluorouracil toxicity |
url |
https://www.termedia.pl/Chemoradiotherapy-for-locally-advanced-pancreatic-cancer-patients-is-it-still-an-open-question-,3,27625,1,1.html |
work_keys_str_mv |
AT emiliasawicka chemoradiotherapyforlocallyadvancedpancreaticcancerpatientsisitstillanopenquestion AT annamironczuk chemoradiotherapyforlocallyadvancedpancreaticcancerpatientsisitstillanopenquestion AT marekzwojtukiewicz chemoradiotherapyforlocallyadvancedpancreaticcancerpatientsisitstillanopenquestion AT ewasierko chemoradiotherapyforlocallyadvancedpancreaticcancerpatientsisitstillanopenquestion |
_version_ |
1725223997194371072 |